Kugeng (KG) Huo, PhD

KG Huo, PhD is a Principal Scientist at Cyagen since June 2022. Prior to that, KG was a Medical Advisor at Berry Genomics from December 2021 to June 2022. KG's previous role was as a Postdoctoral Researcher at University Health Network from January 2018 to November 2021, focusing on novel therapeutics in lung cancer and performing various research and data analysis tasks. KG holds a PhD in Experimental Medicine from McGill University and a Bachelor of Science in Biology from Concordia University.